1999
DOI: 10.1055/s-0037-1614843
|View full text |Cite
|
Sign up to set email alerts
|

Local versus Central Assessment of Venographies in a Multicenter Trial on the Prevention of Deep Vein Thrombosis in Neurosurgery

Abstract: SummaryVenography is the diagnostic method of choice for end-point measurement in multicenter trials on the prevention of postoperative deep vein thrombosis (DVT). The aim of the study was to determine the inter-observer agreement between the local and central assessment of venographies in a multicenter trial comparing enoxaparin and placebo in the prevention of DVT after elective neurosurgery.The study was run in seven centers experienced in venography trials on DVT prevention. The central and local adjudicat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
3
0

Year Published

2001
2001
2017
2017

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 13 publications
2
3
0
Order By: Relevance
“…Despite this methodological rigor, which established that venous ultrasound can be optimized from a logistical point of view to match venography, we failed to demonstrate that it can be used as an alternative for the screening of asymptomatic DVT in this setting. In this trial, inter-observer agreement for centrally adjudicated venography, a measure of internal validity, was excellent, corroborating findings from a previous trial using the same standardized venography technique and the same venography adjudicators [20], and by far exceeded the figures reported in earlier studies [6][7][8][9]; however, it was poor for ultrasound. Agreement between readers for centrally adjudicated CCUS was in the lower range of what would be accepted for a diagnostic test.…”
Section: Discussionsupporting
confidence: 86%
See 2 more Smart Citations
“…Despite this methodological rigor, which established that venous ultrasound can be optimized from a logistical point of view to match venography, we failed to demonstrate that it can be used as an alternative for the screening of asymptomatic DVT in this setting. In this trial, inter-observer agreement for centrally adjudicated venography, a measure of internal validity, was excellent, corroborating findings from a previous trial using the same standardized venography technique and the same venography adjudicators [20], and by far exceeded the figures reported in earlier studies [6][7][8][9]; however, it was poor for ultrasound. Agreement between readers for centrally adjudicated CCUS was in the lower range of what would be accepted for a diagnostic test.…”
Section: Discussionsupporting
confidence: 86%
“…In this trial, inter‐observer agreement for centrally adjudicated venography, a measure of internal validity, was excellent, corroborating findings from a previous trial using the same standardized venography technique and the same venography adjudicators [20], and by far exceeded the figures reported in earlier studies [6–9]; however, it was poor for ultrasound. Agreement between readers for centrally adjudicated CCUS was in the lower range of what would be accepted for a diagnostic test.…”
Section: Discussionsupporting
confidence: 86%
See 1 more Smart Citation
“…It is extremely sensitive in identifying the location, extent, and degree of attachment of a clot. Rossi, et al, 53 state that venography remains the only reliable diagnostic method for DVT detection in patients who are asymptomatic postoperatively, but that it is not a practical screening test. Venography exposes the patient to radiation, it is painful, and it takes approximately 30 to 45 minutes to perform.…”
Section: Screening Methods For Dvtmentioning
confidence: 99%
“…More recently, Rossi et al 8,9 compared the local versus central assessment of venography in a study of the prevention of DVT in elective neurosurgery patients. In this study, 307 patients, all wearing compression stockings, were randomized to receive placebo or enoxaparin (40 mg) once daily.…”
Section: Venography For End-point Measurementmentioning
confidence: 99%